Medication info
Rosuvastatin Calcium 5mg Tablet

Rosuvastatin Calcium 5mg Tablet

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›5.2mg / 1 tablet
Manufacturer / importer
KIMS Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
28 tablets/box [28 tablets (14 tablets/PTPX2)]
Approval status
Active

MFDS item code 201901570 · Approved 2019.03.14 · Insurance code 059600300

Summary

Main use
Improvement of dyslipidemia, prevention of cardiovascular disease, and inhibition of atherosclerosis progression
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Before and during treatment with this medication, patients should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response; it may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medication to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medication to patients with active liver disease. 6. Ethnicity: Since systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medication is contraindicated in some of these patients.
Children's dosage
Age 10 years to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on administering doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
KIMS Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia, prevention of cardiovascular disease, and inhibition of atherosclerosis progression

  • Hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerosis
  • heterozygous familial hypercholesterolemia
  • dysbetalipoproteinemia
  • coronary heart disease
  • elevated high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol
  • smoking
View approved original text

This medication is used as an adjunct to diet for patients with primary hypercholesterolemia and mixed dyslipidemia who cannot be controlled by diet and exercise. It also aids in dietary therapy or other lipid-lowering therapies for patients with homozygous familial hypercholesterolemia. This drug lowers total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, thereby slowing the progression of atherosclerosis. It is also used as a dietary adjunct to reduce cholesterol levels in pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia. It is also used in patients with primary dysbetalipoproteinemia. Additionally, it helps reduce the risk of stroke, myocardial infarction, and vascular revascularization procedures in certain age groups of high-risk cardiovascular disease patients. This medication is used to improve various cardiovascular risks associated with dyslipidemia.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Before and during treatment with this medication, patients should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response; it may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medication to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medication to patients with active liver disease. 6. Ethnicity: Since systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medication is contraindicated in some of these patients.

Children's dosage

Age 10 years to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on administering doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. For example, people who are allergic to any ingredients of this medication, those with severely impaired liver function, and those with muscle diseases should not take it. Women with severe kidney diseases or those who are pregnant or nursing should also refrain from using this medication. It should be used with caution in patients at risk of muscle problems, with high doses prohibited. Patients with specific genetic metabolic issues should not take this medication. It is important to regularly monitor liver function and muscle status while on this medication. If symptoms such as muscle pain or weakness, or sudden fatigue occur, contact a doctor immediately. Additionally, this medication should be administered cautiously to patients who consume large amounts of alcohol or have a history of liver disease, requiring frequent liver function tests if necessary. There are other medications that may increase risks when taken with this medication, so inform your doctor or pharmacist if you are taking any other medications. Women who could become pregnant should use appropriate contraception before taking this medication and discontinue immediately if pregnant. In case of overdose, there is no specific antidote, and treatment should be supportive based on symptoms, monitoring liver function and muscle enzyme levels. This medication does not significantly affect driving or operation of machinery, but caution is advised due to potential dizziness. Lastly, severe adverse reactions like serious skin reactions may occur during treatment, and immediate medical attention should be sought if these symptoms arise.

Side effects

Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, hives, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, drug rash resembling psoriasis, lupus-like syndrome, muscle rupture, arthralgia, immunogenic necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, and the storage temperature should be maintained at room temperature between 1°C and 30°C. Therefore, it is important to avoid direct sunlight and not to place it in extremely hot or cold places.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

28 tablets/box [28 tablets (14 tablets/PTPX2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.